Aryx Therapeutics I Alpha and Beta Analysis

ARYXDelisted Stock  USD 0.0005  0.00  0.00%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Aryx Therapeutics I. It also helps investors analyze the systematic and unsystematic risks associated with investing in Aryx Therapeutics over a specified time horizon. Remember, high Aryx Therapeutics' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Aryx Therapeutics' market risk premium analysis include:
Beta
0.0
Alpha
0.0
Risk
0.0
Sharpe Ratio
0.0
Expected Return
0.0
Please note that although Aryx Therapeutics alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, Aryx Therapeutics did 0.00  better than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Aryx Therapeutics I stock's relative risk over its benchmark. Aryx Therapeutics has a beta of 0.00  . The returns on DOW JONES INDUSTRIAL and Aryx Therapeutics are completely uncorrelated. .
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.

Aryx Therapeutics Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Aryx Therapeutics market risk premium is the additional return an investor will receive from holding Aryx Therapeutics long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Aryx Therapeutics. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Aryx Therapeutics' performance over market.
α0.00   β0.00

Aryx Therapeutics Fundamentals Vs Peers

Comparing Aryx Therapeutics' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Aryx Therapeutics' direct or indirect competition across all of the common fundamentals between Aryx Therapeutics and the related equities. This way, we can detect undervalued stocks with similar characteristics as Aryx Therapeutics or determine the pink sheets which would be an excellent addition to an existing portfolio. Peer analysis of Aryx Therapeutics' fundamental indicators could also be used in its relative valuation, which is a method of valuing Aryx Therapeutics by comparing valuation metrics with those of similar companies.
    
 Better Than Average     
    
 Worse Than Average Compare Aryx Therapeutics to competition
FundamentalsAryx TherapeuticsPeer Average
Return On Asset-0.75-0.14
Current Valuation237.58 K16.62 B
Shares Outstanding33.46 M571.82 M
Shares Owned By Institutions0.14 %39.21 %
Number Of Shares Shorted89.05 K4.71 M
Price To Book37.83 X9.51 X
EBITDA(14.18 M)3.9 B

Aryx Therapeutics Opportunities

Aryx Therapeutics Return and Market Media

The Stock did not receive any noticable media coverage during the period.
 Price Growth (%)  
       Timeline  

About Aryx Therapeutics Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Aryx or other pink sheets. Alpha measures the amount that position in Aryx Therapeutics has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Aryx Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Aryx Therapeutics' short interest history, or implied volatility extrapolated from Aryx Therapeutics options trading.

Build Portfolio with Aryx Therapeutics

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.
You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.

Other Consideration for investing in Aryx Pink Sheet

If you are still planning to invest in Aryx Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Aryx Therapeutics' history and understand the potential risks before investing.
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators